Ayse Busra Gunay Sener

Ayse Busra Gunay Sener

Auto-generated profile, based on publicly available information

Ayse Busra Gunay Sener

Department of Medical Informatics and Biostatistics, Erciyes University Medical Faculty, Kayseri, Turkey

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2023 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
CECem Evereklioglu
Cem Evereklioglu
HSHidayet Sener
Hidayet Sener
OPOsman Ahmet Polat
Osman Ahmet Polat
HSHatice Kubra Sonmez
Hatice Kubra Sonmez
ASAyse Busra Gunay Sener
Ayse Busra Gunay Sener
FHFatih Horozoglu
Fatih Horozoglu

2 January 2023 in Ocular Immunology and Inflammation
Verified
Journal Article
Closed access
HSHidayet Sener
Hidayet Sener
CECem Evereklioglu
Cem Evereklioglu
FHFatih Horozoglu
Fatih Horozoglu
ASAyse Busra Gunay Sener
Ayse Busra Gunay Sener
To examine the long-term efficacy and safety of adalimumab (ADA) in patients with Behçet uveitis (BU).A systematic review and meta-analysis of observational studies was performed. Pooled results ar...

9 June 2023 in Seminars in Ophthalmology
Verified
Journal Article
Closed access
HSHidayet Sener
Hidayet Sener
DSDuygu Gulmez Sevim
Duygu Gulmez Sevim
CECem Evereklioglu
Cem Evereklioglu
MUMuhammed Taha Uludag
Muhammed Taha Uludag
ASAyse Busra Gunay Sener
Ayse Busra Gunay Sener
FHFatih Horozoglu
Fatih Horozoglu
To compare the intraocular pressure (IOP)-lowering effect of different types of surgery available in the literature using a network meta-analysis (NMA) based on a systematic review. PubMed and the Cochrane database were searched. Randomized clinical trials involving surgical interventions for high IOP for PAC (primary angle closure) or PACG (primary angle closure glaucoma) were included. Descriptive statistics and outcomes were extracted. Bayesian NMA was performed to compare the IOP-lowering effect and the change in the number of antiglaucoma drugs required between baseline and endpoint, as well as success rates. This NMA included 21 articles with 1237 eyes with PAC or PACG. Interventions were characterised as phacoemulsification (phaco), trabeculectomy, goniosynechialysis (GSL) with viscoelastic or blunt device, goniosurgery (GS) (trabeculotomy or goniotomy), micro-bypass stent (Istent®), endocyclophotocoagulation (ECPL) or various combinations of these procedures. Phaco+GSL [-1.73 (95%CrI: -3.53 to -0.13)] and phaco+GSL+GS [-3.92 (95%CrI: -6.91 to -1.31)] provided better IOP lowering effects than phaco alone. Phaco+trabeculectomy [-3.11 (95%CrI: -5.82 to -0.44)] was inferior to phaco+GSL+GS. Phaco+trabeculectomy [-0.45 (95%CrI: -0.81 to -0.13)] provided a better outcome in terms of reducing the need for antiglaucoma drug compared to phaco alone. There were no differences between the other surgeries in terms of reduction of antiglaucoma drug number and IOP lowering effect. Success rates were similar for all surgical procedures. Phaco+GSL+GS showed the most promising results for lowering IOP. Phaco+trabeculectomy resulted in a significant reduction in the number of antiglaucoma drugs compared to phaco alone.


14 July 2022 in Seminars in Ophthalmology
Verified
Journal Article
Closed access
HSHidayet Sener
Hidayet Sener
DSDuygu Gulmez Sevim
Duygu Gulmez Sevim
KEKuddusi Erkilic
Kuddusi Erkilic
AOAyse Oner
Ayse Oner
ASAyse Busra Gunay Sener
Ayse Busra Gunay Sener
The aim of this paper was to evaluate the ring amplitudes in diabetic patients and to evaluate the effect of the risk factors for diabetic retinopathy on the ring amplitudes. We also aimed to inves...